CMV Serostatus Mismatch — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Primary CMV disease in the recipient (highest risk serostatus mismatch for CMV disease post-transplant)
D+/R- (donor positive, recipient negative) is the highest-risk CMV serostatus combination for post-transplant CMV disease. The seronegative recipient lacks pre-existing CMV immunity and receives a graft harbouring latent CMV. Without prophylaxis, CMV disease develops in >50% of D+/R- SOT recipients. Management options include universal prophylaxis (Valganciclovir for 3–6 months post-transplant) or pre-emptive monitoring (weekly CMV PCR with treatment if viraemia rises). D+/R- patients receive the longest prophylaxis courses.
Reference: NICE NG37 2016 – SOT: CMV prevention; ECIL-7 2019 – CMV in transplant